KCa3.1 can prevent the progression of bone erosion by inhibiting the differentiation and formation of osteoclasts, thereby relieving the clinical symptoms of RA patients, providing further support for its utility in management of RA. The gene discussed is KCNN4; the disease is rheumatoid arthritis.